In utero azathioprine exposure and increased utilization of special educational services in children born to mothers with systemic lupus erythematosus

Wendy Marder, Martha A Ganser, Vivian Romero, Margaret A Hyzy, Caroline Gordon, W J McCune, Emily C Somers

Research output: Contribution to journalArticlepeer-review

33 Citations (Scopus)

Abstract

Azathioprine (AZA) is recognized among immunosuppressive medications as relatively safe during pregnancy for women with systemic lupus erythematosus (SLE) requiring aggressive treatment. This pilot study aimed to determine whether SLE therapy during pregnancy was associated with developmental delays in offspring.
Original languageEnglish
Pages (from-to)759-66
Number of pages8
JournalArthritis Care & Research
Volume65
Issue number5
DOIs
Publication statusPublished - May 2013

Keywords

  • Adolescent
  • Adult
  • Azathioprine
  • Child
  • Child, Preschool
  • Cohort Studies
  • Developmental Disabilities
  • Education, Special
  • Female
  • Humans
  • Infant
  • Lupus Erythematosus, Systemic
  • Male
  • Pilot Projects
  • Pregnancy
  • Pregnancy Complications
  • Prenatal Exposure Delayed Effects

Fingerprint

Dive into the research topics of 'In utero azathioprine exposure and increased utilization of special educational services in children born to mothers with systemic lupus erythematosus'. Together they form a unique fingerprint.

Cite this